Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
40 Cards in this Set
- Front
- Back
antagonist
|
drug that binds to its recptor and prevents other drugs or substances from producing an effect
|
|
generic name
|
nonproprietary, or common, name of a drug
|
|
Agonist
|
drug that binds to its receptor and produces a drug action
|
|
Drug dependence
|
condition of reliance on the use of a particular drug characterized as physical and/or psychological dependence
|
|
Adverse Effect
|
general term for undesirable and potentially harmful drug effect
|
|
Schedule 3 drug
|
Drug with moderate abuse potential and accepted medical uses
|
|
Drug microsomal metabolizing system (DMMS)
|
group of enzymes located primarily in th eliver that function to metabolize (biotransform) drugs
|
|
Loading dose
|
initial drug dose administered to rapidly achieve therapeutic levels
|
|
Bioavailability
|
percentage of the drug dosage that is absorbed
|
|
mechanism of action
|
explanation of how a drug produces its effect
|
|
Intravenous injection IV
|
drug is injected into the vein
|
|
Drug
|
chemical substance that produces a change in body fuction
|
|
Drug distribution
|
pasage of a drug from the blood to the tissues and organs of the body
|
|
Trade name
|
patened proprietary name of a drug sold by a specific drug manufacturer
|
|
ED50
|
effective dose 50, or dose that will produce an effect that is half of the maximal response
|
|
Drug absorption
|
entrance of a drug into the bloodstream from its site of administration
|
|
Parenteral administration
|
route of drug administration that does not involve the gastointestinal tract GI
|
|
Receptor
|
specific location on a cell membrane or within the cell where the drug attaches toproduce its effect
|
|
Mantinence dose
|
dose administered to maintain drug levels in the therapeutic range
|
|
Schedule V Drug
|
drug with limited abuse potential and accepted medical use
|
|
Drug Indications
|
intended or indicated uses for any drug
|
|
chemical name
|
name that defines the chemical composition of a drug
|
|
Enzyme induction
|
increase in the amount of drug-metaboizing enzymes after repeated administration of certain drugs
|
|
Side effect
|
drug effect other than the therapeutic effect that is usually undesirable but not harmful
|
|
LD50
|
lethal dose 50, or a dose that will kill 50% of the animals tested
|
|
Half-life
|
time required for the body to rid itself of half of the drug dosage that was absorbed (percent bioavailability)
|
|
Site of action
|
location within the body where a drug exerts its therapeutic effect, often a type of receptor
|
|
Dose
|
exact amount of a drug that is administered in order to produce a specific effect
|
|
Therapeutic effect
|
desired drug effect to alleviate some condition or symptom of disease
|
|
Contraindications
|
situations or conditions when a certain drug should not be administered
|
|
Schedule 1 Drug
|
drug with a high abuse potential with no accepted medical use
|
|
Schedule IV Drug
|
drug with limited abuse potential and accepted medical uses
|
|
Drug addiction
|
condition of a drug abuse and drug dependence that is characterized by compulsive drug behavior
|
|
Individual variation
|
difference in the effects of drugs and drug dosages from one person to another due to genetics
|
|
Toxic effect
|
undesirable drug effect that implies drug poisoning, can be harmful or life threatening
|
|
Therapeutic index (TI)
|
ratio of the LD50 to the ED50
|
|
Potency
|
measure of the strength, or concentration, of a drug required to produce a specific effect
|
|
Controlled substance
|
drug that has the potential for abuse and thus is regulated by law
|
|
Schedule 2 Drug
|
drug with high abuse potential and some accepted medical uses
|
|
Intramuscular injection IM
|
route of drug administration, drug is injected into the gluteal or deltoid muscles
|